218 related articles for article (PubMed ID: 25986936)
1. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.
Maudsley S; Martin B; Janssens J; Etienne H; Jushaj A; van Gastel J; Willemsen A; Chen H; Gesty-Palmer D; Luttrell LM
Methods; 2016 Jan; 92():51-63. PubMed ID: 25986936
[TBL] [Abstract][Full Text] [Related]
2. Delineation of a conserved arrestin-biased signaling repertoire in vivo.
Maudsley S; Martin B; Gesty-Palmer D; Cheung H; Johnson C; Patel S; Becker KG; Wood WH; Zhang Y; Lehrmann E; Luttrell LM
Mol Pharmacol; 2015 Apr; 87(4):706-17. PubMed ID: 25637603
[TBL] [Abstract][Full Text] [Related]
3. β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.
Gesty-Palmer D; Yuan L; Martin B; Wood WH; Lee MH; Janech MG; Tsoi LC; Zheng WJ; Luttrell LM; Maudsley S
Mol Endocrinol; 2013 Feb; 27(2):296-314. PubMed ID: 23315939
[TBL] [Abstract][Full Text] [Related]
4. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
5. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
6. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
7. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
8. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
9. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
10. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation.
Gesty-Palmer D; Flannery P; Yuan L; Corsino L; Spurney R; Lefkowitz RJ; Luttrell LM
Sci Transl Med; 2009 Oct; 1(1):1ra1. PubMed ID: 20368153
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
12. Emergent biological properties of arrestin pathway-selective biased agonism.
Appleton KM; Luttrell LM
J Recept Signal Transduct Res; 2013 Jun; 33(3):153-61. PubMed ID: 23448506
[TBL] [Abstract][Full Text] [Related]
13. Conserved class B GPCR activation by a biased intracellular agonist.
Zhao LH; He Q; Yuan Q; Gu Y; He X; Shan H; Li J; Wang K; Li Y; Hu W; Wu K; Shen J; Xu HE
Nature; 2023 Sep; 621(7979):635-641. PubMed ID: 37524305
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic Cleavage of the Extracellular Domain Affects Signaling of Parathyroid Hormone 1 Receptor.
Klenk C; Hommers L; Lohse MJ
Front Endocrinol (Lausanne); 2022; 13():839351. PubMed ID: 35273573
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.
Vilardaga JP; Clark LJ; White AD; Sutkeviciute I; Lee JY; Bahar I
Endocr Rev; 2023 May; 44(3):474-491. PubMed ID: 36503956
[TBL] [Abstract][Full Text] [Related]
16. Functional modulation of PTH1R activation and signaling by RAMP2.
Nemec K; Schihada H; Kleinau G; Zabel U; Grushevskyi EO; Scheerer P; Lohse MJ; Maiellaro I
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2122037119. PubMed ID: 35914163
[TBL] [Abstract][Full Text] [Related]
17. Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics.
Williams GR; Bethard JR; Berkaw MN; Nagel AK; Luttrell LM; Ball LE
Methods; 2016 Jan; 92():36-50. PubMed ID: 26160508
[TBL] [Abstract][Full Text] [Related]
18. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.
Luttrell LM
Mol Endocrinol; 2014 Mar; 28(3):281-94. PubMed ID: 24433041
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.
Yu B; Zhao X; Yang C; Crane J; Xian L; Lu W; Wan M; Cao X
J Bone Miner Res; 2012 Sep; 27(9):2001-14. PubMed ID: 22589223
[TBL] [Abstract][Full Text] [Related]
20. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]